A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer’s disease

Pasqualetti, Patrizio, Bonomini, Cristina, Dal Forno, Gloria, Paulon, Luca, Sinforiani, Elena, Marra, Camillo, Zanetti, Orazio, Maria Rossini, Paolo·2009·Aging Clinical and Experimental Research
DOI 10.1007/bf03325217

Cited by (172)

Items 101–172 of 172

  1. Non-steroidal anti-inflammatory drugs and amyotrophic lateral sclerosis: Results from five prospective cohort studies
    Elinor Fondell, Éilis J. O’Reilly, Kathryn C. Fitzgerald, Guido J. Falcone, Marjorie L. McCullough, Michael J. Thun, Yikyung Park, Laurence N. Kolonel, Alberto Ascherio · 2012 · Amyotrophic Lateral Sclerosis
  2. Investigational medications for treatment of patients with Alzheimer disease.
    Pamela E. Potter · 2010 · PubMed
  3. The use of non-steroidal anti-inflammatory drugs in neurological diseases
    Murat Terzi, Gamze Altun, Sedat Şen, Adem Kocaman, Arife Ahsen Kaplan, Kıymet Kübra Yurt, Süleyman Kaplan · 2017 · Journal of Chemical Neuroanatomy
  4. Microglia as a cellular target of diclofenac therapy in Alzheimer’s disease
    Stopschinski, Barbara E., Weideman, Rick A., McMahan, Danni, Jacob, David A., Little, Bertis B., Chiang, Hsueh-Sheng, Saez Calveras, Nil, Stuve, Olaf · 2023 · Therapeutic Advances in Neurological Disorders
  5. Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner
    Kennedy R. Wiens, Noah A. H. Brooks, Ishvin Riar, Bridget K. Greuel, Ivan A. Lindhout, Andis Klegeris · 2024 · Molecules
  6. Peripheral inflammation and neurodegeneration; a potential for therapeutic intervention in Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS)
    Lourdes Hanna, Edward Poluyi, Chibuikem Anthony Ikwuegbuenyi, Eghosa Morgan, Grace Imaguezegie · 2022 · The Egyptian Journal of Neurosurgery : the official publication of the Egyptian Society of Neurological Surgeons/Egyptian journal of neurosurgery
  7. Independent <scp> <i>APOE4</i> </scp> knock‐in mouse models display reduced brain <scp>APOE</scp> protein, altered neuroinflammation, and simplification of dendritic spines
    Sepulveda, Jordy, Luo, Nancy, Nelson, Matthew, Ng, Christi Anne S., Rebeck, George William · 2022 · Journal of Neurochemistry
  8. Patterns of anti‐inflammatory drug use and risk of dementia: a matched case–control study
    Alex Dregan, Phil Chowienczyk, David Armstrong · 2015 · European Journal of Neurology
  9. Is it All Said for NSAIDs in Alzheimer’s Disease? Role of Mitochondrial Calcium Uptake
    Sara Sanz‐Blasco, María Calvo-Rodríguez, Erica Caballero, Mónica García-Durillo, Lucı́a Núñez, Carlos Villalobos · 2017 · Current Alzheimer Research
  10. An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders
    Antoni Camins, Francesc Xavier Sureda, Fèlix Junyent, Ester Verdaguer, Jaume Folch, Carlos Beas‐Zárate, Mercè Pallàs · 2010 · Expert Opinion on Investigational Drugs
  11. Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
    Sun-Ho Han, Inhee Mook‐Jung · 2014 · Journal of Korean Medical Science
  12. Mechanisms of comorbidity between Alzheimer's disease and pain
    Kaifang Yao, Shenjun Wang, Zhifang Xu, Zezhi Fan, Zhihan Chen, Peng Jia, Shiwei Tu, Yangyang Liu, Xiaowei Lin, Yuan Xu et al. · 2025 · Alzheimer s & Dementia
  13. ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer’s disease
    Madia Lozupone, Giuseppe Berardino, Anita Mollica, Rodolfo Sardone, Vittorio Dibello, Roberta Zupo, Luisa Lampignano, Fabio Castellana, Ilaria Bortone, Roberta Stallone et al. · 2022 · Expert Opinion on Investigational Drugs
  14. Long‐Term Exposure to Non‐Steroidal Anti‐Inflammatory Medication in Relation to Dementia Risk
    Ilse vom Hofe, Bruno H. Ch. Stricker, Muhammad Aimen Ikram, Frank J. Wolters, M. Arfan Ikram · 2025 · Journal of the American Geriatrics Society
  15. A tough trek in the development of an anti-amyloid therapy for Alzheimer's disease: Do we see hope in the distance?
    Jin Jun Luo, William Wallace, John W. Kusiak · 2022 · Journal of the Neurological Sciences
  16. Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
    Alejo J. Nevado‐Holgado, Simon Lovestone · 2016 · Computational and Structural Biotechnology Journal
  17. What to Test in Parkinson Disease Prevention Trials?
    Grace F. Crotty, Michael A. Schwarzschild · 2022 · Neurology
  18. Combination Therapy for the Treatment of Alzheimer’s Disease: Recent Progress and Future Prospects
    Ekta Shirbhate, Vijay K. Patel, Priya Tiwari, Rakesh Kore, Ravichandran Veerasamy, Achal Mishra, Harish Rajak · 2022 · Current Topics in Medicinal Chemistry
  19. Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans
    I‐Fang Ling, Todd Eliot Golde, Douglas R Galasko, Edward H. Koo · 2015 · Alzheimer s Research & Therapy
  20. Failure, Success, and Future Direction of Alzheimer Drugs Targeting Amyloid‐β Cascade: Pros and Cons of Chemical and Biological Modalities
    Jimin Kim, Hanna Jeon, Hye Yun Kim, Young Soo Kim · 2023 · ChemBioChem
  21. Ibuprofen and lipoic acid codrug 1 control Alzheimer's disease progression by down-regulating protein kinase C ε-mediated metalloproteinase 2 and 9 levels in β-amyloid infused Alzheimer's disease rat model.
    S. Zara, M. Rapino, P. Sozio, A. Di Stefano, Cinzia Nasuti, A. Cataldi · 2011 · Brain Research
  22. Recent Studies on Design and Development of Drugs Against Alzheimer’s Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents
    Satya P. Gupta, Vaishali Manikrao Patil · 2020 · Current Topics in Medicinal Chemistry
  23. Periodontitis as a Risk Factor for Alzheimer’s Disease: The Experimental Journey So Far, with Hope of Therapy
    Alice Harding, Shalini Kanagasingam, Richard R. Welbury, Sim K. Singhrao · 2022 · Advances in experimental medicine and biology
  24. Immune modulations and immunotherapies for Alzheimer’s disease: a comprehensive review
    Sara Mahdiabadi, Sara Momtazmanesh, George L. Perry, Nima Rezaei · 2021 · Reviews in the Neurosciences
  25. Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer’s disease: current approaches and future perspectives
    Snigdha Chakraborty, Sukriti Vishwas, Vancha Harish, Gaurav Gupta, Keshav Raj Paudel, Muralikrishnan Dhanasekaran, Bey Hing Goh, Flavia C. M. Zacconi, Terezinha de Jesus Andreoli Pinto, Popat Kumbhar et al. · 2024 · Expert Opinion on Drug Delivery
  26. Amyloid-modifying therapies for Alzheimer’s disease: therapeutic progress and its implications
    Meaghan C. Creed, Norton William Milgram · 2010 · AGE
  27. Review Article Neuroinflammation in Alzheimer's disease: Current evidence and future directions
    Valeria Calsolaro, Paul Edison · 2016
  28. Dementia.
    Rob Butler, Raghavakurup Radhakrishnan · 2012 · PubMed Central
  29. Role of Nonsteroidal Anti-Inflammatory Drugs as a Protective Factor in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
    Akash Asthana, Shashank Tripathi, Rachna Agarwal · 2024 · Neurology India
  30. Role of astroglia and microglia in Alzheimer's disease and multiple therapeutic interventions
    Lei Li, Ying Wang, Qilin Feng, Chaoyang Ma, Cheng He, Wenjun Wan, Lei Tang · 2025 · Journal of Alzheimer s Disease
  31. Apolipoprotein E4 in Alzheimer’s Disease: Role in Pathology, Lipid Metabolism, and Drug Treatment
    Nour F. Al-Ghraiybah, Amer E. Alkhalifa, Yutaka Itokazu, Taylor Farr, Naima Pérez, Hande Ali, Amal Kaddoumi · 2026 · International Journal of Molecular Sciences
  32. Multi-Target-Directed Ligand Approach in Anti-Alzheimer’s Drug Discovery
    Vaishali Manikrao Patil, Neeraj Masand, Vertika Gautam, Shikha Kaushik, Dee H. Wu · 2023 · Springer eBooks
  33. Combination Drug Therapy for the Treatment of Alzheimer’s Disease
    X. Anton Alvarez, Carlos Linares, Eliezer Masliah · 2012 · European Neurological Review
  34. Unraveling APOE4: The dual role in CNS and peripheral inflammation in Alzheimer's disease
    Xiaohan Li, Zekun Li, Hua Chen, Hongmin Guo, Yihao Ge, Fang Dong, Fan Zhang, Feng Zhang · 2025 · International Immunopharmacology
  35. A Systematic Review and Meta-Analysis of Randomized Control Trials to Check Role of Non-Steroidal Anti-inflammatory Drugs as Protective Factor in Alzheimer Disease Subjects
    Akash Asthana, Shashank Tripathi, Rachna Agarwal · 2023 · Advances in Alzheimer s Disease
  36. Diabetes and cognitive dysfunction
    Bhumsoo Kim, Catrina Sims‐Robinson, Stacey A. Sakowski, Eva L. Feldman · 2022 · Elsevier eBooks
  37. Therapeutic Strategies in Neurodegenerative Diseases
    Kristi M. Anderson, Rodney Lee Mosley · 2016 · Springer eBooks
  38. Microwave-assisted synthesis and in vitro stability of N-benzylamide non-steroidal anti-inflammatory drug conjugates for CNS delivery
    Brandon D. Eden, Andrew J. Rice, Troy D. Lovett, Olivia M. Toner, Evan P Geissler, William E. Bowman, Sherri C. Young · 2019 · Bioorganic & Medicinal Chemistry Letters
  39. Molecular Imaging of Neuroinflammation in Alzheimer’s Disease and Mild Cognitive Impairment
    Junhyung Kim, Yong‐Ku Kim · 2023 · Advances in experimental medicine and biology
  40. Are Inflammatory Profiles the Key to Personalized Alzheimer's treatment?
    Holly M. Brothers, Donna M. Wilcock · 2013 · Neurodegenerative Disease Management
  41. REVIEW ON EVALUATING THE ROLE OF NSAIDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
    Prayaga Rajappan Krishnendu, B. Arjun, K. VIBINA, NIVEA CLEO T. S., N. K. DRISYA, RADHIKA MOHANDAS, Subin Mary Zachariah, Subin Mary Zachariah · 2021 · International Journal of Applied Pharmaceutics
  42. Influence of Ibuprofen on glycerophospholipids and sphingolipids in context of Alzheimer´s Disease
    Juliane Radermacher, Vincent Konrad Johannes Erhardt, Oliver Walzer, Elodie Christiane Haas, Konstantin Nicolas Kuppler, Jill Sven René Zügner, Anna Andrea Lauer, Tobias Hartmann, Heike S. Grimm, Marcus O.W. Grimm · 2025 · Biomedicine & Pharmacotherapy
  43. Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein
    Masayo Fujita, Gilbert J. Ho, Yoshiki Takamatsu, Ryoko Wada, Kazutaka Ikeda, Makoto Hashimoto · 2020 · International Journal of Molecular Sciences
  44. Translatability of Animal Models for Alzheimer's Disease Using a Machine Learning Based Workflow
    Alex Foster‐Powell, Guy M. L. Meno‐Tetang, Amin Rostami‐Hodjegan, Kayode Ogungbenro, Donald E. Mager · 2025 · Clinical and Translational Science
  45. Ibuprofen-Glutathione Conjugate as Anti-inflammatory and Anti-apoptotic Agent in Rat Brain Infused with β Amyloid (1-40)
    De Colli M Sozio P · 2012 · Journal of Cytology & Histology
  46. Alzheimer’s Disease: An Insightful Review on the Future Trends of the Effective Therapeutics
    Afreen Hashmi, Vivek Srivastava, Syed Abul Kalam, Devesh Kumar Mishra · 2022 · IntechOpen eBooks
  47. Stress oxydant et maladie d’Alzheimer
    Thomas Gilbert, Jocelyne Drai, Marc Bonnefoy · 2013 · Springer eBooks
  48. Ibuprofen in Prevention of Neurodegenerative Diseases
    Kim Drummond Rainsford · 2015 · Wiley eBooks
  49. Drug Discovery from Medicinal Plants against Alzheimer's Disease
    Mona M. Marzouk, Mai Mohammed Farid, Nesrine Mahmoud Hegazi, Shahira M. Ezzat · 2023 · Wiley eBooks
  50. Pijn bij dementie: van experiment tot betere zorg
    Wilco P. Achterberg, Leids Universitair, Erik Scherder · 2010
  51. Pharmacological Approaches and Herbal Interventions for Alzheimer's Disease
    Shivendra Kumar, Shubham Singh, Dharmendra Rajput, Bhawna Sharma, Kumkum Chaturvedi, Nidhi Singh, Sunam Saha, Kuldeep Singh, Soumyadip Mukherjee · 2024 · The Natural Products Journal
  52. Cytokines in Neurodegenerative Disorders
    Kalipada Pahan · 2024 · Springer eBooks
  53. Loneliness Modulates Inflammation to Affect the Neurocognitive Function of Older Adults
    Rachel R. Jin, Aidan Kai Yeung Chan, Tatia M.C. Lee · 2024 · Integrated science
  54. Médicaments et cognition chez le sujet âgé
    Christine Brefel‐Courbon · 2015 · Therapies
  55. Direct- And Spacer-Coupled Codrug Strategies for the Treatment of Alzheimer's Disease
    Erika Fornasari, Vita Di Stefano, Ivana Cacciatore · 2014
  56. Alzheimer’s Disease: Beyond the Neuron
    Aradhana Verma, Matthew K. Zabel · 2018 · InTech eBooks
  57. Inflammation and insulin resistance in Alzheimer’s disease
    Yuval Nash, Dan Frenkel · 2020 · Elsevier eBooks
  58. The future of dementia prevention and treatment strategies
    里 直行 · 2020 · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
  59. Anti-inflammatory therapy and cerebrospinal fluid diagnosis in Alzheimer's disease.
    Daniëlle de Jong · 2010 · Radboud Repository (Radboud University)
  60. Current and Prospective Treatments for Alzheimer's Disease (and Other Neurodegenerative Diseases)
    Steve Pedrini, Mike Morici, Ralph Nigel Martins · 2019 · Wiley eBooks
  61. Nomethiazoles: PK/PD Study of a Novel Class of Alzheimer’s Disease Therapeutics
    Ehsan Tavassoli · 2012 · Figshare
  62. Efecto de las manipulaciones genéticas y farmacológicas sobre la actividad del complejo gamma-secretasa
    Cristina Guardia‐Laguarta · 2010 · TDX (Tesis Doctorals en Xarxa)
  63. Dynamics of amyloid plaque formation in Alzheimer’s Disease
    Joanna F McCarter · 2014 · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München)
  64. [List of scientific publications].
    Patrizio Pasqualetti · 1951 · PubMed
  65. Investigation into multifunctional nanoparticles for the detection, imaging and intervention of amyloid
    Yang Xia · 2019
  66. Interactions of Aβ1-42 Peptide and Its Three Fragments (Aβ8-12, Aβ8-13, and Aβ5-16) with Selected Nonsteroidal Drugs and Compounds of Natural Origin
    Krzysztof Żamojć, Karolina Streńska, Dariusz Wyrzykowski, Lech Chmurzyński, Joanna Makowska · 2020 · Symmetry
  67. Current awareness in geriatric psychiatry
    John Wiley & Sons, Ltd. · 2009 · International Journal of Geriatric Psychiatry
  68. Current awareness in human psychopharmacology
    2009 · Human Psychopharmacology Clinical and Experimental
  69. Animal Models of Amyloid/PS-1 Pathology
    Akihiko Takashima · 2011 · Royal Society of Chemistry eBooks
  70. Immune dysregulation and neurodegenerative diseases
    Virginia Cipollini, Fernanda Troili, Franco Giubilei · 2023 · Elsevier eBooks
  71. Etude d’une cible thérapeutique pour la maladie d’Alzheimer et mise au point de nouveaux modèles cellulaires de criblage
    Emilie Dorard · 2016 · theses.fr (ABES)
  72. Étude des perturbations astrocytaires sous l’influence de l’apolipoprotéine E4 : implications et applications dans la maladie d’Alzheimer
    Laurie Arnaud · 2021 · theses.fr (ABES)